REG - FIL Limited Medtronic, Inc. Covidien plc - Form 8.3 - COVIDIEN PLC <Origin Href="QuoteRef">COV.N</Origin> <Origin Href="QuoteRef">MDT.N</Origin>

MedtronicAnnouncement

12/11/2014 16:00

RNS Number : 8686W
FIL Limited
12 November 2014
FORM 8.3
 IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2007 (AS AMENDED)
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1)
 FMR LLC and/or one or more of its direct or indirect subsidiaries
And
FIL Limited and/or one or more of its direct and indirect subsidiaries
Company dealt in
COVIDIEN PLC
Class of relevant security to which the dealings being disclosed relate(Note 2)
Ordinary shares
Date of dealing
11-November-14
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security
dealt in(Note 3)
Long
Short
Number (%)
Number (%)
(1) Relevant securities 
17,194,832 3.80

(2) Derivatives (other than options)
 
 
(3) Options and agreements to purchase/sell
 
 
Total
17,194,832 3.80
 
b) Interests and short positions in relevant securities of the company, other than the
class dealt in(Note 3)
Class of relevant security:
Long
Short
Number (%)
Number (%)
(92) Relevant securities 
 
 
(2) Derivatives (other than options)
 
 
(3) Options and agreements to purchase/sell
 
 
Total
 
 
3. DEALINGS(Note 4)
(91) Purchases and sales
Purchase/sale
Number of securities
Price per unit
Sale
165,000
93.4676 USD/ Share
Sale
36,500
93.71 USD/ Share
Sale
67,049
93.6614 USD/ Share
Sale
14,838
93.5751 USD/ Share
Sale
22,075
93.5995 USD/ Share
Sale
12,417
93.6487 USD/ Share
Sale
12,549
93.6104 USD/ Share
Sale
600
93.59 USD/ Share
Sale
2,220
93.6391 USD/ Share
Sale
3,880
93.4059 USD/ Share
Sale
5,100
93.3528 USD/ Share
Sale
8,372
93.4114 USD/ Share
Buy
36,501
93.71 USD/ Share
Buy
7
93.25 USD/ Share
Buy
81
92.65 USD/ Share
Buy
2
92.75 USD/ Share
Sale
69
92.74 USD/ Share
Sale
1
92.63 USD/ Share
Sale
5
93.27 USD/ Share
(b) Derivatives transactions (other than options transactions)
Product name, 
e.g. CFD
Nature of transaction (Note 6)
Number of securities (Note 7)
Price per unit (Note 5)




(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name,
e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise
price 
Type, e.g. American, European etc.
Expiry 
date
Option money
paid/received per unit (Note 5) 







(ii) Exercising
Product name, e.g. call option
Number of securities 
Exercise price per unit (Note 5)


(d) Other dealings (including transactions in respect of new securities)(Note 4)
Nature of transaction (Note 8)
Details
Price per unit (if applicable)(Note 5)


4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. 
Is a Supplemental Form 8 attached?(Note 9)NO
Date of disclosure
12 November 2014
Contact name
Nevelina Rousseva-Gasnier
Telephone number
+44 (0)1737 837216
If a connected EFM, name of offeree/offeror with which connected
N/A
If a connected EFM, state nature of connection (Note 10)
N/A

This information is provided by RNS
The company news service from the London Stock Exchange
  END
ISELLFESLELFLIS